Zolgensma Provides No Proven Benefit Over Spinraza In SMA, Says German HTA

IQWiG Laments Lack Of Comparative Data

 
• By Francesca Bruce
  
SMA
German HTA Compares SMA Treatments • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography